
Kinomica
Developer of a phosphoproteomic diagnostic platform designed to enhance tailored treatment decisions involving anticancer drug therapies. The company's platform provides a suite of advanced proprietar...
Valuation
$16.6M
Latest known
Share Price
N/A
Total Raised
$13.1M
Last Round
N/A